CELEX: 62015CA0296
Language: en
Date: 2017-06-08 00:00:00
Title: Case C-296/15: Judgment of the Court (Third Chamber) of 8 June 2017 (request for a preliminary ruling from the Državna revizijska komisija za revizijo postopkov oddaje javnih naročil — Slovenia) — Medisanus d.o.o. v Splošna Bolnišnica Murska Sobota (Reference for a preliminary ruling — Public procurement — Medicinal products for human use — Directive 2004/18/EC — Article 2 and Article 23(2) and (8) — Articles 34 and 36 TFEU — Public contract for supplying a hospital — National legislation requiring that hospitals are to be supplied as a matter of priority with medicinal products obtained from national plasma — Principle of equal treatment)

31.7.2017   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 249/3
            
         Judgment of the Court (Third Chamber) of 8 June 2017 (request for a preliminary ruling from the Državna revizijska komisija za revizijo postopkov oddaje javnih naročil — Slovenia) — Medisanus d.o.o. v Splošna Bolnišnica Murska Sobota
   (Case C-296/15) (1)
   
   ((Reference for a preliminary ruling - Public procurement - Medicinal products for human use - Directive 2004/18/EC - Article 2 and Article 23(2) and (8) - Articles 34 and 36 TFEU - Public contract for supplying a hospital - National legislation requiring that hospitals are to be supplied as a matter of priority with medicinal products obtained from national plasma - Principle of equal treatment))
   (2017/C 249/03)
   Language of the case: Slovenian
   
      Referring court
   
   Državna revizijska komisija za revizijo postopkov oddaje javnih naročil
   
      Parties to the main proceedings
   
   
      Applicant: Medisanus d.o.o.
   
      Defendant: Splošna Bolnišnica Murska Sobota
   
      Operative part of the judgment
   
   Article 2 and Article 23(2) and (8) of Directive 2004/18/EC of the European Parliament and of the Council of 31 March 2004 on the coordination of procedures for the award of public works contracts, public supply contracts and public service contracts, and Article 34 TFEU read in conjunction with Article 36 TFEU, must be interpreted as precluding a clause in the tender specifications for a public contract which, in accordance with the law of the Member State to which the contracting authority belongs, requires medicinal products derived from plasma, which are the subject matter of the public procurement at issue, to be obtained from plasma collected in that Member State.
   
      (1)  OJ C 346, 19.10.2015.